Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02567201
Other study ID # 69HCL15_0216
Secondary ID 2015-A00635-44
Status Recruiting
Phase N/A
First received
Last updated
Start date October 16, 2015
Est. completion date October 15, 2025

Study information

Verified date February 2024
Source Hospices Civils de Lyon
Contact Jacques LUAUTE, MD
Phone 4. 27. 85. 62. 96
Email jacques.luaute@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aim : To assess the ability of healthy subjects and patients with a severe motor disability to voluntary control their attention Material and Methods: Population: healthy subjects, patients with brain injury Electroencephalographic study to research attentional modulation during different kind of stimulation (visual, auditory, tactile) Sudy 1: passive recording. Study 2: active recording (instruction of attentional control given to the subject). Study 3: active recording with a feedback obtained after a processing of the brain activity.


Recruitment information / eligibility

Status Recruiting
Enrollment 420
Est. completion date October 15, 2025
Est. primary completion date October 15, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: Inclusion criteria for patients : - Adults, man or woman, left or right-handed, from 18 years old to 80 years-old ; - Diagnosis : - Locked-in syndrome : < Brainstem injury, without any evolution for at least 3 week, etiology : vascular, traumatic < Amyotrophic Lateral Sclerosis < Following damage to the central or peripheral nervous system - Or Minimal conscious state or Unresponsive Wakefulness Syndrome consecutive to a severe acquired brain injury for at least one month - Or with a severe brain injury, since birth or acquired, for at least one month - Or with Guillain-Barré syndrome - Subjects affiliated to social security; - Signature of consent form by the patient or by a relative (family member or "the trusted person") if obtaining a consent is impossible Inclusion criteria of Healthy subjects - Adults, man or woman, left or right-handed, from 18 years old to 80 years-old ; - Without known auditory impairment - Subjects able to understand the experimental instructions - Subjects affiliated to social security; - Signature of consent form Exclusion criteria of patients and healthy subjects - Medical history : psychiatric disorders (except if due to brain injury), neurologic disorders (except if due to brain injury) - For healthy subjects : history of brain injury - Pregnant women or breastfeeding women - Person under legal protection - Medico-legal conflicts - Absence of consent by the subject or the patient or his/her representant

Study Design


Related Conditions & MeSH terms


Intervention

Other:
electrophysiological evaluation
electrophysiological assessment (experience 1 : passive ; experience 2 : active versus passive ; experience 3 : active, with feedback) Experience 1, 2, 3 : one session maximum by experience
electrophysiological evaluation of patients
electrophysiological assessment (experience 1 : passive ; experience 2 : active versus passive ; experience 3 : active, with feedback) Experience 1 : maximum one session by sensory modality of stimulation (auditory, tactile, or visual) Experience 2 : maximum one session by sensory modality of stimulation (auditory, tactile, or visual) Experience 3 : Stimulation = auditory or visual ; possibility of several sessions if the patient is tired.

Locations

Country Name City State
France Centre Médical de L'argentière Aveize
France Centre Hospitalier Georges Claudinon Le Chambon Feugerolles
France Centre de Recherche en Neurosciences de Lyon Lyon
France Hospices Civils de Lyon Lyon
France CHU de Nantes Nantes
France CHU de Nîmes Nîmes
France APHP - Hôpital de la Pitié Salpêtrière Paris
France APHP - Hôpital Raymond Poincaré Paris
France Hôpital Nord CHU Saint Etienne Saint-Étienne
France Hospices civils de Lyon, Hôpital Henry Gabrielle, Saint-Genis-Laval
France Centre Médical Germaine Revel Saint-Maurice-sur-Dargoire

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Research of statistical differences between sensory evoked potentials in attentional oriented condition and distracted condition stastical analysis allowing to compare evoked responses during different stimulation condition (attentionnaly oriented versus attentionnally distracted versus passive condition = no instruction to the subject). These comparisons are made either for one single subject and at the group level. Analysis mainly concerns the differences in amplitude variation between the differents evoked potentials on several electrods of interest. These can vary between patients because of the different topographies of lesions and because of the different adaptative strategies. The statiscal difference will be assessed by a randomization test (also called "permutation test") wich allow to assess how high is the risk that the observed difference between the evoked potential (amplitude, variance) is due to chance or not through study completion, an average of 3 years
Secondary Online and offline accuracy percentage of correct answers with the brain-computer interface (BCI). A "correct answer" is recorded each time the feedback of the BCI match the command sended by the subject controlling the BCI. This analysis can be done online and offline. Online accuracy is recorded in real-time during the session with the subject. offline accuracy is obtained a posteriori of the experiment, to test the impact on accuracy of the changes in different parameters (stimuli duration, numbers of spatial filtering, change of classifiers, etc.). through study completion, an average of 3 years.
Secondary Clinical scale score ("Evaluation de la Communication des patients en Eveil de Coma" (ECEC) scale) this clinical scale allow to obtain an outcome measure of the investissment, the communication themes and the communication modes of the patient. The final global value range between 0 and 44. an average of 3 years (At the group level)
See also
  Status Clinical Trial Phase
Completed NCT02710123 - Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion N/A
Recruiting NCT02777060 - Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures N/A
Completed NCT02262286 - MIND (Management of Traumatic Brain Injury Diagnosis) N/A
Completed NCT01461902 - Vasospasm in Pediatric Traumatic Brain Injury N/A
Recruiting NCT01198964 - Optimization of Human Cortical Stimulation
Active, not recruiting NCT01207050 - Effect of Rozerem on Sleep Among People With Traumatic Brain Injury Phase 4
Completed NCT01201863 - Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy Phase 4
Completed NCT00875329 - Traumatic Brain Injury (TBI) Screening Instruments N/A
Completed NCT01059890 - Cerebral Antibiotics Distribution After Acute Brain Injury Phase 1
Completed NCT01035606 - Training in Goal-directed Attention Regulation for Individuals With Brain Injury N/A
Completed NCT00596765 - Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury N/A
Completed NCT00571623 - Automated Chest Physiotherapy to Improve Outcomes in Neuro N/A
Completed NCT00336466 - The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS) Phase 2
Recruiting NCT05105763 - Biofeedback Gait Retraining for Stiff Knee Gait Correction N/A
Recruiting NCT02495558 - Cough Assessment in Patients With Severe Acquired Brain Injury N/A
Completed NCT02100592 - Early Verticalization in neuroICU With ERIGO: a Safety and Feasibility Study Phase 1/Phase 2
Completed NCT00797680 - Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest Phase 2
Completed NCT00018499 - Genotype Influence on Recovery After Traumatic Brain Injury N/A
Withdrawn NCT05581927 - Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE) N/A
Completed NCT02615119 - Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa N/A